Search
Search Results
Found 13 items.
-
Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy
Published: December 31, 20132571PDF: 2009 -
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience
Published: December 31, 20171432PDF: 747 -
History of infantile BCG immunization did not predict lamina propria invasion and/or high-grade in patients with non-muscle invasive bladder cancer
Published: May 31, 2023617PDF: 367 -
Does intravesical bacillus Calmette-Guérin for bladder cancer protect from COVID-19?
Published: May 9, 2024624PDF: 208 -
Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists
Published: March 19, 2024965PDF: 225 -
Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis
Published: March 18, 20211461PDF: 947Supplementary Material: 150 -
HER2/neu expression status of post BCG recurrent non-muscle-invasive bladder urothelial carcinomas in relation to their primary ones
Published: May 30, 2023859PDF: 359 -
Prognostic impact of ReTURB in high grade T1 primary bladder cancer
Published: July 4, 20162139PDF: 1250 -
Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer
Published: June 28, 20211046PDF: 424 -
-
-
New concept in urologic surgery: The total extended genital sparing radical cystectomy in women
Published: May 22, 20231485PDF: 568
1 - 13 of 13 items